Compound Detail
CHEMBL150
KAEMPFEROL Phase I
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Phase I
Basic Information
| ChEMBL ID | CHEMBL150 |
| Name | KAEMPFEROL |
| Phase | Phase I |
| Structure Type | MOL |
| InChI Key | IYRMWMYZSQPJKC-UHFFFAOYSA-N |
91
Targets
162
Activities
4
Assay Types
3
PK Parameters
20
Publications
19
Known Names
1
Indications
Molecular Properties
286.2
MW (Da)
2.28
ALogP
6
HBA
4
HBD
111.1
PSA (Ų)
0.55
QED
0
Ro5 Violations
1
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Indications
Sexual Dysfunction, Physiological
Activity Summary
IC50 133 meas. best 7.55
Ki 18 meas. best 7.6
EC50 9 meas. best 5.52
Kd 2 meas. best 5.17
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Carbonic anhydrase 7 CHEMBL2326 | Ki | 7.6 | 7.6 | 25.0 | 1 |
| Aryl hydrocarbon receptor CHEMBL3201 | IC50 | 7.55 | 7.55 | 28.0 | 1 |
| Cytochrome P450 1B1 CHEMBL4878 | Ki | 7.37 | 7.37 | 43.0 | 1 |
| Cytochrome P450 1B1 CHEMBL4878 | IC50 | 7.33 | 7.33 | 47.0 | 1 |
| CDGSH iron-sulfur domain-containing protein 1 CHEMBL1795168 | Ki | 6.88 | 6.88 | 132.0 | 1 |
| Carbonic anhydrase 12 CHEMBL3242 | Ki | 6.84 | 6.84 | 145.9 | 1 |
| Casein kinase 2 CHEMBL3832943 | Ki | 6.68 | 6.68 | 210.0 | 1 |
| Entamoeba histolytica CHEMBL612853 | IC50 | 6.64 | 6.64 | 230.0 | 1 |
| Sulfotransferase 1A1 CHEMBL4886 | IC50 | 6.54 | 6.54 | 290.0 | 1 |
| 17-beta-hydroxysteroid dehydrogenase type 2 CHEMBL2789 | IC50 | 6.44 | 6.44 | 360.0 | 2 |
| Casein kinase 2 CHEMBL3832943 | IC50 | 6.4 | 6.4 | 400.0 | 1 |
| Casein kinase 2 CHEMBL3988629 | IC50 | 6.4 | 6.4 | 400.0 | 1 |
| Dipeptidyl peptidase 4 CHEMBL284 | IC50 | 6.31 | 5.745 | 490.0 | 2 |
| Cytochrome P450 1A1 CHEMBL2231 | IC50 | 6.2 | 6.2 | 632.0 | 1 |
| Cytochrome P450 1A2 CHEMBL3356 | IC50 | 6.14 | 6.14 | 716.0 | 1 |
| Cytochrome P450 1A1 CHEMBL2231 | Ki | 6.12 | 6.12 | 750.0 | 1 |
| NON-PROTEIN TARGET CHEMBL3879801 | IC50 | 6.08 | 5.07 | 840.0 | 2 |
| Tyrosinase CHEMBL1973 | IC50 | 6.0 | 5.095 | 1000.0 | 2 |
| 17-beta-hydroxysteroid dehydrogenase type 1 CHEMBL3181 | IC50 | 5.98 | 5.98 | 1050.0 | 1 |
| Xanthine dehydrogenase/oxidase CHEMBL1929 | IC50 | 5.97 | 5.97 | 1060.0 | 1 |
| NADPH oxidase 4 CHEMBL1250375 | IC50 | 5.92 | 5.92 | 1200.0 | 1 |
| Aldo-keto reductase family 1 member B1 CHEMBL2622 | IC50 | 5.88 | 5.88 | 1330.0 | 1 |
| Osteoclast CHEMBL612548 | IC50 | 5.8 | 5.8 | 1600.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 5.77 | 4.685 | 1700.0 | 14 |
| Ribosomal protein S6 kinase alpha-3 CHEMBL2345 | IC50 | 5.77 | 5.77 | 1710.0 | 1 |
| Histone deacetylase 6 CHEMBL1865 | IC50 | 5.77 | 5.77 | 1714.0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 CHEMBL4358 | IC50 | 5.66 | 5.66 | 2200.0 | 1 |
| Myeloperoxidase CHEMBL2439 | IC50 | 5.65 | 5.65 | 2240.0 | 1 |
| Receptor-type tyrosine-protein kinase FLT3 CHEMBL1974 | IC50 | 5.63 | 5.63 | 2320.0 | 1 |
| Multidrug resistance-associated protein 1 CHEMBL3004 | Ki | 5.62 | 5.62 | 2400.0 | 2 |
| Inositol hexakisphosphate kinase 2 CHEMBL4523488 | IC50 | 5.6 | 5.6 | 2500.0 | 1 |
| Monocyte CHEMBL614076 | IC50 | 5.57 | 5.135 | 2700.0 | 2 |
| Polyunsaturated fatty acid 5-lipoxygenase CHEMBL215 | IC50 | 5.57 | 5.57 | 2700.0 | 1 |
| SARS-CoV-2 CHEMBL4303835 | EC50 | 5.52 | 5.52 | 3000.0 | 1 |
| CDGSH iron-sulfur domain-containing protein 1 CHEMBL1795168 | IC50 | 5.51 | 5.51 | 3100.0 | 1 |
| Glycogen synthase kinase-3 CHEMBL2095188 | IC50 | 5.46 | 5.46 | 3500.0 | 1 |
| Short transient receptor potential channel 5 CHEMBL1250411 | IC50 | 5.41 | 5.41 | 3900.0 | 1 |
| Solute carrier family 2, facilitated glucose transporter member 1 CHEMBL2535 | IC50 | 5.4 | 5.4 | 4000.0 | 1 |
| 3-oxoacyl-acyl-carrier protein reductase CHEMBL4513 | IC50 | 5.4 | 5.4 | 4000.0 | 1 |
| Inositol polyphosphate multikinase CHEMBL4523401 | IC50 | 5.36 | 5.36 | 4400.0 | 1 |
| No relevant target CHEMBL2362975 | IC50 | 5.33 | 4.7433 | 4730.0 | 3 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 CHEMBL5393 | IC50 | 5.33 | 5.27 | 4700.0 | 2 |
| Cytochrome P450 2C9 CHEMBL3397 | Ki | 5.22 | 5.22 | 6000.0 | 1 |
| ATP-dependent translocase ABCB1 CHEMBL2573 | Kd | 5.17 | 5.17 | 6700.0 | 1 |
| ATP-dependent translocase ABCB1 CHEMBL4302 | Kd | 5.17 | 5.17 | 6760.8 | 1 |
| Tyrosine-protein kinase Yes CHEMBL2073 | Ki | 5.17 | 5.17 | 6770.0 | 1 |
| HepG2 CHEMBL395 | EC50 | 5.11 | 5.11 | 7740.0 | 1 |
| Sialidase CHEMBL5189 | IC50 | 5.1 | 5.1 | 8000.0 | 1 |
| Trypanosoma brucei brucei CHEMBL612851 | IC50 | 5.05 | 5.05 | 9000.0 | 1 |
| BV-2 CHEMBL614781 | IC50 | 5.05 | 4.45 | 8860.0 | 6 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 269.0 | mL.min-1.g-1 | Homo sapiens |
| Ka | 1.43 | 10'5/M | Homo sapiens |
| T1/2 | 0.02 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine